2.2.2. Administration of Midazolam via the Intranasal MAD
The participant was provided with a simplified explanation of the drug administration process. A dose of midazolam at 0.3 mg/kg (Mezolam, Neon Laboratories Ltd.) was administered using an intranasal mucosal atomizer device (MAD) (LMA MAD Nasal™, Wolfe Tory Medical Inc., USA) attached to a two mL syringe. The patient's acceptance of the drug was assessed using a scale developed by al-Rakaf et al. [